Evidence mapPaperPMID 41854080Full record

ArticleNucleic acids research2026

Regulation of YAP activity by nuclear G-actin binding.

Hong Wang, Irma M Jayawardana, Justus M Fleisch, Dennis Frank, Bing Zhao, Christos Kamaras, Peter Gebhardt, Julian Knerr, Svenja Ulferts, Shamphavi Sivabalasarma and 2 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hong WangInstitute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg, 79104, Freiburg, Germany.ORCID 0000-0002-3120-1679
Irma M JayawardanaInstitute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg, 79104, Freiburg, Germany.ORCID 0009-0003-4991-820X
Justus M FleischInstitute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg, 79104, Freiburg, Germany.ORCID 0009-0004-8484-8881
Dennis FrankInstitute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg, 79104, Freiburg, Germany.ORCID 0000-0003-0139-7751
Bing ZhaoInstitute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg, 79104, Freiburg, Germany.
Christos KamarasInstitute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg, 79104, Freiburg, Germany.ORCID 0009-0003-2866-8109
Peter GebhardtInstitute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg, 79104, Freiburg, Germany.
Julian KnerrInstitute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg, 79104, Freiburg, Germany.ORCID 0000-0002-2614-6185
Svenja UlfertsInstitute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg, 79104, Freiburg, Germany.ORCID 0000-0002-6605-8163
Shamphavi SivabalasarmaSpemann Graduate School of Biology and Medicine, University of Freiburg, 79104, Freiburg, Germany.ORCID 0000-0002-2491-8292
Sonja-Verena AlbersCentre for Integrative Biological Signalling Studies-CIBSS, University of Freiburg, 79104, Freiburg, Germany.ORCID 0000-0003-2459-2226
Robert GrosseInstitute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, University of Freiburg, 79104, Freiburg, Germany.ORCID 0000-0002-3380-5273

Funding

Deutsche Forschungsgemeinschaft 403222702-SFB 1381Deutsche Forschungsgemeinschaft 431984000European Research Council 101142324Germany's Excellence Strategy EXC-2189 390939984University of Freiburg
6 · The paper itself

Abstract

The Yes-associated protein YAP belongs to the TEAD (TEA/ATTS domain) transcriptional co-activators that shuttle between the cytoplasm and the nuclear compartment. YAP and its paralog TAZ (transcriptional co-activator with PDZ-binding motif) play essential roles in the Hippo pathway to control tissue and organ size. In addition, YAP is critically involved in numerous cellular processes such as differentiation, proliferation, cell migration, and cancer metastasis, as well as mechanotransduction and cytoskeletal dynamics. The actin cytoskeleton controls YAP activity in multiple ways via tensile forces, cell density and cell-cell adhesion as well as shear stress or other biomechanical cues. Here we discover YAP as a novel G-actin binding protein. We identify three high-affinity YAP actin binding sites involving critical residues within the N-terminus of YAP. Moreover, actin binding to YAP is necessary for its transcriptional activity and function, such as during cell density control. Mutation of the three actin-binding residues results in a loss of nuclear YAP co-activator function towards TEAD, while actin binding to YAP is required for TEAD target gene regulation. Our data point towards the formation of a dynamic TEAD/YAP/actin ternary complex necessary for transcription.

Indexed as

ActinsAdaptor Proteins, Signal TransducingCell NucleusPhosphoproteinsTranscription FactorsAnimalsBinding SitesCell Cycle ProteinsHumansProtein BindingYAP-Signaling ProteinsActinsAdaptor Proteins, Signal TransducingCell Cycle ProteinsPhosphoproteinsTranscription FactorsYAP1 protein, humanYAP-Signaling Proteins

Identifiers

PMID41854080
PMCPMC13000468

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.